WSJ The Abortion Pill Mifepristone Comes Back to the Supreme Court
Wall Street Journal
Last updated: May 6, 2026
An appeals court ruled against a federal policy allowing prescription drugs to be mailed without a doctor's visit. Justice Samuel Alito has temporarily halted any changes to this policy pending a Supreme Court review. This decision impacts how certain medications can be accessed.
- The core issue revolves around the federal regulation that permits mail-order dispensing of drugs, a process that bypasses the need for an in-person doctor's consultation.
- An appeals court has challenged this established policy, ruling against its continuation.
- In response to this ruling, Justice Samuel Alito has intervened, issuing a stay to prevent any immediate alteration of the existing dispensing practice.
- This temporary halt ensures that the current system remains in place while the Supreme Court considers the matter further.
- The Supreme Court's eventual decision will determine the future legality and accessibility of mail-order drug dispensing without a prior physician examination.
- This legal development has significant implications for patients, pharmaceutical companies, and the broader healthcare landscape concerning medication access and regulatory oversight.
